Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Early Phase 1
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02949687Not ApplicableWithdrawn

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

Role: lead

NCT02427763Early Phase 1Completed

Microbiological and Epithelial Evaluation Related to the Use of Orthodontic Thermoplastic Device

Role: lead

NCT02393053Not ApplicableCompleted

Non-Pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions

Role: lead

NCT01151176Phase 4Suspended

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Role: lead

All 4 trials loaded